LabCorp
LH
#1055
Rank
NZ$40.70 B
Marketcap
NZ$496.39
Share price
-0.19%
Change (1 day)
15.67%
Change (1 year)
Laboratory Corporation of America Holdings or LabCorp is a US company that offers clinical laboratory services. The company supplies laboratory results for the diagnosis of diseases and the development of new drugs.

EPS for LabCorp (LH)

EPS in 2026 (TTM): NZ$19.40

According to LabCorp's latest financial reports the company's current EPS (TTM) is NZ$19.87. In 2025 the company made an earnings per share (EPS) of NZ$18.41 an increase over its 2024 EPS that were of NZ$15.55.

EPS history for LabCorp from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$19.405.37%
2025NZ$18.4118.45%
2024NZ$15.5589.15%
2023NZ$8.22-66.26%
2022NZ$24.36-43.33%
2021NZ$42.9854.11%
2020NZ$27.8989.43%
2019NZ$14.72-3.33%
2018NZ$15.23-29.7%
2017NZ$21.6775.74%
2016NZ$12.3363.19%
2015NZ$7.55-28.4%
2014NZ$10.55-6.13%
2013NZ$11.245.2%
2012NZ$10.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IDEXX Laboratories
IDXX
NZ$23.96 20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$16.04-19.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$1.47-107.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.60-81.87%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.37-101.85%๐Ÿ‡บ๐Ÿ‡ธ USA